![Steven Mayer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Mayer
Direttore/Membro del Consiglio presso Bellus Health (Innodia), Inc.
Provenienza dei contatti di primo grado di Steven Mayer
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
HBM Partners AG
![]() HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.
13
| Private Company | Investment Managers | 13 |
Bellus Health (Innodia), Inc.
![]() Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Subsidiary | Medical Specialties | 5 | |
Emergent Technologies, Inc.
![]() Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas.
4
| Private Company | Investment Managers | 4 |
Pure Transplant Solutions, LLC
![]() Pure Transplant Solutions, LLC Medical SpecialtiesHealth Technology Pure Transplant Solutions LLC develops diagnostics, devices and therapeutics. The firm develops medical devices which will eliminate rejection in organ transplants. The company is headquartered in Austin, TX.
3
| Holding Company | Medical Specialties | 3 |
GlucoSentient, Inc.
![]() GlucoSentient, Inc. Medical/Nursing ServicesHealth Services GlucoSentient, Inc. develops personal glucose meters for diabetes patients. It has developed a technology that is transforming the personal glucose meter into a device that is detecting other non-glucose targets. The firm offers products such as Medical Diagnostics, Point-of-care tests, Immunoassay. The company was founded by Brian Wong, Tian Lan, Neil D. Kane and Yi Lu in 2011 and is headquartered in Champaign, IL.
3
| Holding Company | Medical/Nursing Services | 3 |
Psynova Neurotech Ltd.
![]() Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom.
2
| Subsidiary | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Steven Mayer tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
LUMINEX CORPORATION | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BELLUS HEALTH | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer General Counsel | |
Neusentis, Inc.
![]() Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gynesonics, Inc.
![]() Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
Symbiomix Therapeutics LLC
![]() Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Biotechnology | Director/Board Member | |
Southern Methodist University
![]() Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Undergraduate Degree Undergraduate Degree | |
CDP Capital Private Equity
![]() CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London. | Investment Managers | Private Equity Investor Chief Investment Officer | |
McGill University | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
The University of Texas at Austin | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
INSEAD | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
University of Illinois | College/University | Corporate Officer/Principal Doctorate Degree | |
University of Montréal | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
ESBATech, a Novartis Co. GmbH
![]() ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ziemer Group AG
![]() Ziemer Group AG Medical SpecialtiesHealth Technology Ziemer Group AG develops, manufactures, and markets diagnostic and surgical ophthalmic products. Its products include FEMTO LDV, AMADEUS, GALILEI and PASCAL. The company was founded by Frank Ziemer in 1998 and is headquartered in Port, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Director/Board Member Chairman | |
CardiacAssist, Inc.
![]() CardiacAssist, Inc. Medical SpecialtiesHealth Technology CardiacAssist, Inc. develops, manufactures and markets medical devices. The firm’s products include TandemLife Kit, TandemHeart Kit, TandemLung Kit, ProtekDuo Kit and educational videos. The company was founded by John C. Marous, Jr. and George J. Magovern in 1996 and is headquartered in Pittsburgh, PA. | Medical Specialties | Director/Board Member | |
University of Basel | College/University | Doctorate Degree Graduate Degree | |
Freie Universität Berlin | College/University | Doctorate Degree | |
Myriad RBM, Inc.
![]() Myriad RBM, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT. | Miscellaneous Commercial Services | President Chief Tech/Sci/R&D Officer | |
Neurochem (International) Ltd.
![]() Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal General Counsel | |
i-Optics BV
![]() i-Optics BV Medical SpecialtiesHealth Technology i-Optics BV develops and produces eye diagnosis and therapeutic solutions. Its lead product, the EasyScan, that provides non-mydriatic retina imaging camera for the diagnosis of diabetic retinopathy and macular degeneration. The firm engages in the development and marketing of retina and cornea imaging solutions. The company was founded by Michiel Mensink and is headquartered in The Hague, the Netherlands. | Medical Specialties | Director/Board Member | |
Beacon Sciences LLC
![]() Beacon Sciences LLC BiotechnologyHealth Technology Beacon Sciences LLC operates as a biotechnology company. The firm platform utilizes supra-molecular recognition chemistry rather than antibodies or enzymes to create a binding event in an assay. Its applications include medical diagnostics, biowarfare detection, molecular tools, environmental monitoring, food and beverage testing, chronic disease monitoring, and pre-clinical drug safety testing. The company was founded by Eric V. Anslyn in 2007 and is headquartered in Austin, TX. | Biotechnology | Corporate Officer/Principal | |
Receptor Logic, Inc.
![]() Receptor Logic, Inc. Pharmaceuticals: MajorHealth Technology Receptor Logic, Inc. provides a novel solution for the treatment of infectious diseases and cancers. The company was founded by Jon Weidanz in 2003 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Chief Executive Officer President | |
Choncept LLC
![]() Choncept LLC Pharmaceuticals: MajorHealth Technology Choncept LLC produces biotechnology products. It develops chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products. The company was founded by Paul L. DeAngelis in 2002 and is headquartered in Oklahoma City, OK. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Pure Protein LLC
![]() Pure Protein LLC Pharmaceuticals: MajorHealth Technology Pure Protein LLC specializes in immunology tools for diagnostics, drug and vaccine development, and high-yield protein production. It operates as a biopharmaceutical company, produces soluble human leukocyte antigen (sHLA) proteins and custom products in various human and animal cell lines. The firm provides sHLA class I and II proteins for use in transplantation, drug target discovery, and bio-therapeutic development, as well as diagnostic and therapeutic reagents for use in immunology research and development. The company was founded by William Hildebrand in 1999 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Chief Executive Officer Private Equity Investor | |
Selenium Ltd.
![]() Selenium Ltd. Chemicals: SpecialtyProcess Industries Selenium Ltd. develops develops anti-microbial, anti-fungal and anti-neoplastic properties. It operates as a biopharmaceutical company specializing in the prevention of bacterial biofilm formation using molecular coatings of redox active selenium for medical, dental, ophthalmic and industrial applications. The company was founded by Julian Spallholz and Ted Reid in 2004 and is headquartered in Austin, TX. | Chemicals: Specialty | Chief Executive Officer Corporate Officer/Principal | |
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Pharmaceuticals: Generic | Chairman Founder | |
Cathay Industrial Biotech Ltd.
![]() Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Cathay Industrial Biotech Ltd. develops, manufactures, and commercializes chemicals, fuels, and polymers. It offers dibasic acids, pentamethylene diamine, terryl for textiles, engineering polymers, toll production, and technology development. The company was founded by XiuCai Liu and QiXian Zhang in 1997 and is headquartered in Shanghai, China. | Chemicals: Specialty | Director of Finance/CFO | |
Cell Medica Switzerland AG
![]() Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Galecto Biotech ApS
![]() Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
HBM Healthcare Investments (Cayman) Ltd.
![]() HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Hospital/Nursing Management | Chief Executive Officer Director/Board Member | |
HBM Partners AG (Investment Management)
![]() HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Investment Managers | Chief Executive Officer Analyst-Equity | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
Pure MHC LLC
![]() Pure MHC LLC Medical SpecialtiesHealth Technology Pure MHC LLC provides diagnostics and therapeutics technology services. It offers epitope discovery solution where it identifies peptide epitopes that are upregulated in the affected state and validated as ligands presented by human leukocyte antigen (HLA) molecules and T cell receptor mimics (TCRms) technology, monoclonal antibodies that function like T-cell receptor. The firm also provides regulatory compliance support and existing target validation and tissue distribution services. The company was founded by William Hildebrand in 2013 and is headquartered in Austin, TX. | Medical Specialties | Chief Executive Officer President | |
Vitaeris, Inc.
![]() Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Fore Biotherapeutics, Inc.
![]() Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Dren Bio, Inc.
![]() Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
River 2 Renal Corp.
![]() River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology River 2 Renal Corp. develops novel therapies targeting orphan diseases in the renal space. The private company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
River 3 Renal Corp. | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 28 |
Canada | 9 |
Svizzera | 9 |
Germania | 3 |
Isole Cayman | 3 |
Settori
Health Technology | 33 |
Consumer Services | 9 |
Finance | 4 |
Commercial Services | 4 |
Process Industries | 3 |
Posizioni
Director/Board Member | 160 |
Corporate Officer/Principal | 47 |
Chairman | 30 |
Founder | 28 |
Chief Executive Officer | 28 |
Contatti più connessi
Insiders | |
---|---|
Francesco Bellini | 27 |
Klaas de Boer | 27 |
Louis P. Lacasse | 26 |
Chandra Paul Leo | 22 |
André L. Lamotte | 21 |
Andreas Wicki | 21 |
Alexander G. Asam | 18 |
Thomas Craig Benson | 17 |
Thomas A. Harlan | 15 |
Eric Emile Swenden | 13 |
Pavel Hamet | 13 |
Priyanka Belawat | 10 |
Kris Looney | 9 |
Shona McDiarmid | 9 |
Beat R. Merz | 9 |
- Borsa valori
- Insiders
- Steven Mayer
- Connessioni Società